Clinical Trial Update: Effects of EVT 302 With or Without NRT on Craving and Withdrawal in Healthy Male Smokers Deprived of Cigarettes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating EVT 302 with or without nicotine replacement therapy on craving and withdrawal in healthy male smokers deprived of cigarettes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• EVT 302
• Nicotine replacement therapy (NRT) (nicotine)

Snippet

Sponsor: Evotec Neurosciences GmbH | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED